Bryant Amy E, Aldape Michael J, Bayer Clifford R, Katahira Eva J, Bond Laura, Nicora Carrie D, Fillmore Thomas L, Clauss Therese R W, Metz Thomas O, Webb-Robertson Bobbie-Jo, Stevens Dennis L
U.S. Department of Veterans Affairs, Office of Research and Development, Boise, ID, United States of America.
University of Washington School of Medicine, Seattle, WA, United States of America.
PLoS One. 2017 Feb 28;12(2):e0172486. doi: 10.1371/journal.pone.0172486. eCollection 2017.
Acute muscle injuries are exceedingly common and non-steroidal anti-inflammatory drugs (NSAIDs) are widely consumed to reduce the associated inflammation, swelling and pain that peak 1-2 days post-injury. While prophylactic use or early administration of NSAIDs has been shown to delay muscle regeneration and contribute to loss of muscle strength after healing, little is known about the effects of delayed NSAID use. Further, NSAID use following non-penetrating injury has been associated with increased risk and severity of infection, including that due to group A streptococcus, though the mechanisms remain to be elucidated. The present study investigated the effects of delayed NSAID administration on muscle repair and sought mechanisms supporting an injury/NSAID/infection axis.
A murine model of eccentric contraction (EC)-induced injury of the tibialis anterior muscle was used to profile the cellular and molecular changes induced by ketorolac tromethamine administered 47 hr post injury.
NSAID administration inhibited several important muscle regeneration processes and down-regulated multiple cytoprotective proteins known to inhibit the intrinsic pathway of programmed cell death. These activities were associated with increased caspase activity in injured muscles but were independent of any NSAID effect on macrophage influx or phenotype switching.
These findings provide new molecular evidence supporting the notion that NSAIDs have a direct negative influence on muscle repair after acute strain injury in mice and thus add to renewed concern about the safety and benefits of NSAIDS in both children and adults, in those with progressive loss of muscle mass such as the elderly or patients with cancer or AIDS, and those at risk of secondary infection after trauma or surgery.
急性肌肉损伤极为常见,非甾体类抗炎药(NSAIDs)被广泛用于减轻损伤后1 - 2天达到峰值的相关炎症、肿胀和疼痛。虽然已表明预防性使用或早期给予NSAIDs会延迟肌肉再生并导致愈合后肌肉力量丧失,但对于延迟使用NSAIDs的影响知之甚少。此外,非穿透性损伤后使用NSAIDs与感染风险和严重程度增加有关,包括由A组链球菌引起的感染,但其机制仍有待阐明。本研究调查了延迟给予NSAIDs对肌肉修复的影响,并寻找支持损伤/NSAIDs/感染轴的机制。
使用小鼠胫骨前肌离心收缩(EC)诱导损伤模型,以分析损伤后47小时给予酮咯酸氨丁三醇所诱导的细胞和分子变化。
给予NSAIDs抑制了几个重要的肌肉再生过程,并下调了多种已知可抑制程序性细胞死亡内在途径的细胞保护蛋白。这些活动与受伤肌肉中半胱天冬酶活性增加有关,但与NSAIDs对巨噬细胞流入或表型转换的任何影响无关。
这些发现提供了新的分子证据,支持NSAIDs对小鼠急性拉伤损伤后肌肉修复有直接负面影响这一观点,从而增加了对NSAIDs在儿童和成人、肌肉量逐渐减少的人群(如老年人、癌症或艾滋病患者)以及创伤或手术后有继发感染风险人群中的安全性和益处的新关注。